Premium
Adrenergic beta 2 ‐selective blocker in isoprenaline‐enhanced essential tremor
Author(s) -
Teräväinen Heikki,
Huttunen Juha
Publication year - 1987
Publication title -
movement disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.352
H-Index - 198
eISSN - 1531-8257
pISSN - 0885-3185
DOI - 10.1002/mds.870020204
Subject(s) - isoprenaline , propranolol , antagonist , essential tremor , adrenergic , beta (programming language) , adrenergic receptor , chemistry , pharmacology , beta blocker , medicine , endocrinology , receptor , heart failure , stimulation , computer science , physical medicine and rehabilitation , programming language
A beta 2 ‐selective adrenergic‐receptor‐blocking drug, ICI 118.551,150 mg/day, prevented almost as effectively as the nonselective antagonist propranolol, 240 mg/day, the isoprenaline enhancement of essential tremor amplitude.